US President Donald Trump announced yesterday that the US Food
and Drug Administration has allowed Gilead Sciences to urgently use its experimental anti-viral treatment, Remediesiver, to treat people with the emerging corona virus, as scientists compete globally to develop vaccines and treatments to reduce the pandemic. . The CEO of the company, Daniel Audi, described the procedure during a meeting with "Trump" at the White House, as an important first step, and said that the company donated a million and a half million doses of the drug to help patients, saying: "We want to make sure that there are no obstacles regarding The drug reaches those infected with the virus. Anthony Stephen Fuchi, the American immunologist, director of the National Institute of Allergy and Infectious Diseases, who works on the White House team to combat the virus, praised the clinical results of the
treatment, as it provided a glimmer of hope towards the treatment of the virus, as it speeds up the cure for those with COFED- 19 ", so he described it as a" very important first step "in treatment. Therefore, you can get to know the drug with us on the following points, according to the American newspaper "New York Post" news website: The drug RemedyVir - an experimental antiviral drug, developed by the American drug company "Gilead Sciences" - was originally intended to combat the Ebola virus after the outbreak of the disease in 2013, but he failed to treat the disease. - Despite its initial failures, it has been proven effective against both SARS and the Middle East SKN virus, and has been tested in clinical trials to ensure its suitability to treat the emerging virus "COFED-19", according to the news website "Digital Trends".
Currently, remedisiver is the most effective treatment for the best results in controlling the virus, according to researcher with molecular viruses at the University of Maine in the United States of America, Melissa Magnes. REMEDIVIVIR - The treatment targets the virus without damaging the other cells of the patient. - It speeds up the cures of the virus, as the National Institute of Allergy and Infectious Diseases in the United States issued that those who took "Remisevir" were cured after 11 days, while those who did not take it took 15 days to recover. - The results of clinical trials conducted on more than 1000 people with new Corona, showed their response to treatment. The percentage of improvement was 31%, and
response to treatment was rapid, according to the National Institute of Allergy and Infectious Diseases. About the side effects of treatment, a study launched by the drug manufacturer revealed that nausea, difficulty breathing, and elevated liver enzymes are the most negative reactions, and the drug is used by intravenous injection. Treatment is just a testable drug, not a miracle cure. American doctors need to know more about treatment, but consider the drug a precursor to better treatments for the disease. Remediffer has obtained the license required to start using it on patients,
particularly "in an emergency". REEDDESIVER - The US National Institute of Infectious Diseases questioned the drug, saying that "the results are positive, but modest." - China has raised doubts about the drug, saying that "remedisfer" is absolutely ineffective with the new Corona virus, and that the results of its experiments have proven to be a failure. On April 28th, Japan announced that it would adopt Remediffer as a treatment for HIV patients.
تعليقات
إرسال تعليق